IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 41 filers reported holding IMMUNE DESIGN CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 3.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,441,000 | -50.6% | 443,790 | -31.9% | 0.00% | -100.0% |
| Q3 2016 | $4,940,000 | +10.1% | 651,726 | +18.6% | 0.00% | 0.0% |
| Q2 2016 | $4,486,000 | -38.1% | 549,736 | -1.4% | 0.00% | -50.0% |
| Q1 2016 | $7,247,000 | -33.1% | 557,427 | +3.3% | 0.00% | 0.0% |
| Q4 2015 | $10,837,000 | +199.6% | 539,686 | +82.0% | 0.00% | +100.0% |
| Q3 2015 | $3,617,000 | -41.0% | 296,469 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $6,130,000 | +68.7% | 296,851 | +72.4% | 0.00% | 0.0% |
| Q1 2015 | $3,634,000 | -29.7% | 172,152 | +2.6% | 0.00% | 0.0% |
| Q4 2014 | $5,167,000 | +95.1% | 167,869 | +12.0% | 0.00% | 0.0% |
| Q3 2014 | $2,648,000 | – | 149,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,962,720 | $16,016,000 | 6.52% |
| Abingworth LLP | 197,300 | $1,610,000 | 1.69% |
| NEXTHERA CAPITAL LP | 85,138 | $695,000 | 0.60% |
| Cormorant Asset Management, LP | 432,990 | $3,533,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 153,000 | $1,248,000 | 0.32% |
| TFS CAPITAL LLC | 102,685 | $838,000 | 0.15% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,227,595 | $10,017,000 | 0.10% |
| Eventide Asset Management | 180,000 | $1,469,000 | 0.09% |
| Focused Wealth Management, Inc | 15,868 | $129,000 | 0.06% |
| Spark Investment Management LLC | 77,500 | $632,000 | 0.06% |